Vaccine against Ebola: Commission grants new market authorisations

The European Commission has adopted the decision granting marketing authorisations to the company Janssen, a Johnson & Johnson company, for a vaccine against Ebola. The authorisation was granted in one month, reducing the decision-making process timing in half, further demonstrating the Commission's commitment in placing the protection of public health as a priority.